Anzeige
Mehr »
Login
Freitag, 03.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Schnelle Produktionsaufnahme: Multi-Tenbagger-Potenzial direkt in Spanien?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
13 Leser
Artikel bewerten:
(0)

Global and Chinese Nalbuphine HCL Industry Report 2014

DUBLIN, Oct. 30, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global and Chinese Nalbuphine HCL Industry Report 2014" report to their offering.

http://photos.prnewswire.com/prnh/20130307/600769

Global and Chinese Nalbuphine HCL Industry Report 2014 is a professional and in-depth study on the current state of the global Nalbuphine HCLindustry with a focus on the Chinese situation.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Nalbuphine HCL market analysis is provided for both the international and Chinese domestic situations including development trends, competitive landscape analysis, key regions development status and a comparison analysis between the international and Chinese markets.

Development policies and plans are also discussed and manufacturing processes and cost structures analyzed. Nalbuphine HCL industry import/export consumption, supply and demand figures and cost price and production value gross margins are also provided.

The report focuses on eleven industry players providing information such as company profiles, product picture and specification, capacity production, price, cost, production value and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Nalbuphine HCL industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 131 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Key Topics Covered:

Chapter One Nalbuphine HCL Industry Overview



Chapter Two Nalbuphine HCL International and China Market Analysis

Chapter Three Nalbuphine HCL Technical Data and Manufacturing Plants Analysis

Chapter Four Nalbuphine HCL Production by Regions By Technology By Applications

Chapter Five Nalbuphine HCL Manufacturing Process and Cost Structure

Chapter Six 2009-2014 Nalbuphine HCL Productions Supply Sales Demand Market Status and Forecast

Chapter Seven Nalbuphine HCL Key Companies Analysis

Chapter Eight Up and Down Stream Industry Analysis

Chapter Nine Nalbuphine HCL Marketing Channels Analysis

Chapter Ten Nalbuphine HCL Industry Development Trend

Chapter Eleven Nalbuphine HCL Industry Development Proposals

Chapter Twelve Nalbuphine HCL New Project Investment Feasibility Analysis

Chapter Thirteen Global and China Nalbuphine HCL Industry Research Conclusions

Companies Mentioned:

  • Acme
  • Dr Reddy's
  • Glenmark
  • Global Pharmaceuticals
  • HOSPIRA
  • Humanwell
  • Incepta Pharmaceuticals
  • Manusaktteva
  • Opsonin
  • Sami
  • Squarepharma

For more information visit http://www.researchandmarkets.com/research/txw7q2/global_and

Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net

Kupfer - Jetzt! So gelingt der Einstieg in den Rohstoff-Trend!
In diesem kostenfreien Report schaut sich Carsten Stork den Kupfer-Trend im Detail an und gibt konkrete Produkte zum Einstieg an die Hand.
Hier klicken
© 2014 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.